CTNNB1 and neoplasm: Similarly, assessment of CTNNB1 exon 3 mutations in paired samples showed that 4 of 24 patients (16.7%) harboured mutations only in tumour tissue, with no cases presenting mutations restricted to non-tumour tissue (p = 0.1092; Table 3).